Patents Assigned to The Medical College of Ohio
-
Patent number: 5876978Abstract: A method and apparatus for quantitative measurement of gene expression through multiplex competitive reverse transcriptase polymerase chain reaction amplification are disclosed. The method and apparatus are especially useful for analysis of small specimens of cells and tissues.Type: GrantFiled: June 16, 1997Date of Patent: March 2, 1999Assignee: Medical College of OhioInventors: James C. Willey, Erin L. Crawford, Jeffery P. DeMuth, Clara M. Jackson, David A. Weaver
-
Patent number: 5866323Abstract: This invention is based on the discovery that the type II TGF-.beta. receptor (RII) is a cancer suppressor gene which is genetically inactivated (mutated) in approximately 25% of colon cancers, including nearly all colon cancers of the class identified as mutator/microsatellite instability/RER. Methods are provided for detecting inactivation of RII for use in cancer diagnosis or prognosis.Type: GrantFiled: May 22, 1995Date of Patent: February 2, 1999Assignees: Case Western Reserve University, Medical College of OhioInventors: Sanford D. Markowitz, Michael G. Brattain, James K. V. Willson
-
Patent number: 5853450Abstract: The method of treating wastewater or bioorganic sludges containing odor, animal viruses, pathogenic bacteria, and parasites to produce a bioactive but stabilized product that is useful as a soil substitute or as a fertilizer which can be applied directly to lands which consists essentially of the following steps: mixing said sludge with at least one alkaline material, wherein the amount of added material mixed with said sludge is sufficient to raise the pH of said mixture to pH 12, and raise the conductivity to disinfect and stabilize the sludge, and adding green waste at different process locations so that a biological action occurs converting the greenwaste into a soil-like granular product with improved odor over that of the treated municipal sludge alone or a composted greenwaste alone.Type: GrantFiled: September 3, 1997Date of Patent: December 29, 1998Assignee: Medical College of OhioInventors: Jeffrey C. Burnham, Frederick H. Kurtz
-
Patent number: 5853590Abstract: A method of treating sludge to provide a stable product for use as a beneficial soil or fertilize for agricultural lands is disclosed which includes the steps of:(a) mixing sludge with at least one alkaline material in an amount sufficient to raise pH of the mixture to a level of at least 12 and to increase percent of solids in the mixture to at least 40% by weight, and such that odorant sludge organics and inorganics are bound to adsorbent particles of the alkaline material,(b) aerating and drying the mixture by agitation and heating to stabilize the mixture and increase the percent solids to at least 50% by weight, and(c) pasteurizing the dried mixture at a temperature at or above 52.degree. C.Type: GrantFiled: September 3, 1997Date of Patent: December 29, 1998Assignee: Medical College of OhioInventor: Jeffrey C. Burnham
-
Patent number: 5837484Abstract: Stable packaging cell lines derived from human 293 cells which are transfected with an AAV vector having the AAV rep gene operably line to a heterologous transcription promoter, such as the metallothionein promoter, or an AAV Rep78 insensitive homologous promoter and which are capable of producing AAV Rep proteins and being useful for packaging recombinant AAV vectors containing target polynucleotides.Type: GrantFiled: January 9, 1995Date of Patent: November 17, 1998Assignee: Medical College of OhioInventors: James P. Trempe, Qicheng Yang
-
Patent number: 5744598Abstract: Purified imines of porphyrins, chlorins, bateriochlorins, chlorophylls, bacteriochlorophylls, purpurins, reduced purpurins, verdins, Diels Alder adducts, benzochlorins and metal complexes of the foregoing imines are disclosed. The formulas of the benzochlorinimines and of the benzochlorinimine metal complexes are set forth below: ##STR1## In specific examples, M in the metal complexes is a copper cation that is complexed with two of the nitrogens of the benzochlorinimine R' and R"" are methyl, and R1 through R8 are ethyl.Type: GrantFiled: April 29, 1996Date of Patent: April 28, 1998Assignees: University of Toledo, Medical College of OhioInventors: Dimitris Skalkos, Steven H. Selman, James A. Hampton, Alan R. Morgan
-
Patent number: 5714334Abstract: The subject invention concerns novel polynucleotide sequences which code for polypeptides which bind IgA. A further aspect of the invention are hybrid proteins (and genes encoding these hybrid proteins) which comprise binding domains for both IgA and IgG. The invention also pertains to methods for detecting IgA.Type: GrantFiled: January 7, 1997Date of Patent: February 3, 1998Assignee: Medical College of OhioInventor: Ervin Faulmann
-
Patent number: 5693632Abstract: Families of Diels Alder adducts and of metal complexes of Diels Alder adducts, which are useful as particularly active compounds for use in photodynamic therapy, are disclosed. The Diels Alder adducts and a preferred family of metal complexes have the structures of Formulas 1, 2, 3 and 4, below: ##STR1## where R1, R2, R3 and R4 can be the same or different, and each is methyl, ethyl or an amino acid moiety which is a part of an amide produced by reaction between an amine function of a naturally occurring amino acid and a carbonyl function of the adduct, R5, R6 and R7 can be the same or different, and each is ethyl or an amino acid moiety which is a part of an amide produced by reaction between an amine function of a naturally occurring amino acid and a carbonyl function of the adduct, M comprises metal cation.Type: GrantFiled: November 6, 1996Date of Patent: December 2, 1997Assignees: The University of Toledo, The Medical College of OhioInventors: Alan R. Morgan, Steven H. Selman
-
Patent number: 5665347Abstract: The invention relates to a method of suppressing B1 cell activity in a host (e.g., mammalian, including human) comprising administering to the host an effective amount of IL-12 that significantly suppresses or inhibits B1 cell activity. In addition, the invention relates to a method of treating a B1 cell disorder in a host, comprising administering to the host an effective therapeutic amount of IL-12. The invention further encompasses a method of screening for substances (e.g., proteins, peptides, small molecules) which enhance or suppress the inhibition of B1 cell activity by IL-12. The invention also relates to a substance identified by the methods of screening for a substance which enhances or suppresses IL-12 inhibition of B1 cell activity.Type: GrantFiled: February 2, 1995Date of Patent: September 9, 1997Assignees: Genetics Institute, Medical College of OhioInventors: Dennis W. Metzger, Victor H. Van Cleave
-
Patent number: 5644030Abstract: The subject invention concerns novel polynucleotide sequences which code for polypeptides which bind IgA. A further aspect of the invention are hybrid proteins (and genes encoding these hybrid proteins) which comprise binding domains for both IgA and IgG.Type: GrantFiled: April 27, 1995Date of Patent: July 1, 1997Assignee: Medical College of OhioInventor: Ervin Faulmann
-
Patent number: 5587394Abstract: Families of Diels Alder adducts and of metal complexes of Diels Alder adducts, which are useful as particularly active compounds for use in photodynamic therapy, are disclosed. The Diels Alder adducts and a preferred family of metal complexes have the structures of Formulas 1, 2, 3 and 4, below: ##STR1## where R1, R2, R3 and R4 can be the same or different, and each is methyl, ethyl or an amino acid moiety which is a part of an amide produced by reaction between an amine function of a naturally occurring amino acid and a carbonyl function of the adduct, R5, R6 and R7 can be the same or different, and each is ethyl or an amino acid moiety which is a part of an amide produced by reaction between an amine function of a naturally occurring amino acid and a carbonyl function of the adduct.Type: GrantFiled: June 7, 1995Date of Patent: December 24, 1996Assignees: The University of Toledo, Medical College of OhioInventors: Alan R. Morgan, Steven H. Selman
-
Patent number: 5563262Abstract: Families of Diels Alder adducts and of metal complexes of Diels Alder adducts, which are useful as particularly active compounds for use in photodynamic therapy, are disclosed. The Diels Alder adducts and a preferred family of metal complexes have the structures of Formulas 1, 2, 3 and 4, below: ##STR1## where R1, R2, R3 and R4 can be the same or different, and each is methyl, ethyl or an amino acid moiety which is a part of an amide produced by reaction between an amine function of a naturally occurring amino acid and a carbonyl function of the adduct, R5, R6 and R7 can be the same or different, and each is ethyl or an amino acid moiety which is a part of an amide produced by reaction between an amine function of a naturally occurring amino acid and a carbonyl function of the adduct, M comprises a metal cation, e.g., Sn or Zn, that is complexed with two of the nitrogens of the adduct, and R8 is an alkyl group other than t-butyl having from one to four carbon atoms.Type: GrantFiled: October 11, 1994Date of Patent: October 8, 1996Assignees: University of Toledo, Medical College of OhioInventors: Alan R. Morgan, Steven H. Selman
-
Patent number: 5552134Abstract: A family of benzochlorins, a family of verdins, a family of porphyrin derivatives and metal complexes thereof are disclosed. The benzochlorins have the formula of FIG. 3 of the attached drawings; their metal complexes have the formula of FIG. 1. The verdins have the formula of FIG. 4 of the attached drawings; their metal complexes have the formula of FIG. 2. The porphyrin derivatives have the formula of FIG. 7 of the attached drawings; their metal complexes have the formula of FIG. 8. Solutions of the benzochlorins, verdins, porphyrin derivatives and metal complexes which are physiologically acceptable for intravenous administration are also disclosed, as are emulsions or suspensions of the solutions, and compositions which additionally include cyclodextrin, and wherein the molecules of the benzochlorin, verdin, porphyrin derivative or metal complex are encapsulated within the molecules of the cyclodextrin. The solvent for the solutions can be a product of the reaction of ethylene oxide with castor oil.Type: GrantFiled: June 7, 1995Date of Patent: September 3, 1996Assignees: University of Toledo, Medical College of OhioInventors: Alan R. Morgan, Steven H. Selman
-
Patent number: 5534506Abstract: The treatment of blood and other body fluids and tissues, the detection of tumors and the treatment of patients is disclosed. The treatment and detection involve the use of families of chlorins, families of purpurins and families of metal complexes of chlorins and purpurins. The purpurins and their metal complexes have the structures of FIGS. 1 , 7, 14-18, 29-38, 44-48 and 54-58 of the attached drawings. The chlorins and their metal complexes have the formulas of FIGS. 2 , 8, 19, 20, 22, 23, 24, 25, 27, 28, 39, 40, 42, 43 and 49-53 of the attached drawings. Solutions of the purpurins, of the foregoing and other chlorins and of the metal complexes which are physiologically acceptable for intravenous administration are also disclosed, as are emulsions or suspensions of the solutions. The solvent for the solutions can be a product of the reaction of ethylene oxide with castor oil.Type: GrantFiled: June 20, 1994Date of Patent: July 9, 1996Assignees: University of Toledo, Medical College of Ohio, St. Vincent Medical CenterInventors: Alan R. Morgan, Steven H. Selman, Martha Kreimer-Birnbaum
-
Patent number: 5514669Abstract: The present invention provides a method for diagnosing or treating prostatic tissue in a human or animal patient which comprises sensitizing the prostatic tissue with an effective amount of a photosensitive composition which accumulates in the prostatic tissue and exposing the sensitized tissue to a source of light energy for a predetermined time and intensity sufficient to cause cellular and/or tissue function of the sensitized prostatic tissue to diminish or cease.Type: GrantFiled: September 29, 1993Date of Patent: May 7, 1996Assignee: Medical College of OhioInventor: Steven H. Selman
-
Patent number: 5512559Abstract: Purified imines of porphyrins, chlorins, bateriochlorins, chlorophylls, bacteriochlorophylls, purpurins, reduced purpurins, verdins, Diels Alder adducts, benzochlorins and metal complexes of the foregoing imines are disclosed. The formulas of the benzochlorinimines and of the benzochlorinimine metal complexes are set forth below: ##STR1## In specific examples, M in the metal complexes is a copper cation that is complexed with two of the nitrogens of the benzochlorinimine R' and R"" are methyl, and R1 through R8 are ethyl.Type: GrantFiled: January 19, 1995Date of Patent: April 30, 1996Assignee: The University of Toledo and Medical College of OhioInventors: Dimitris Skalkos, Steven H. Selman, James A. Hampton
-
Patent number: 5486459Abstract: The invention is directed to biological processes and apparatus for determining the efficacy of a sterilization cycle based upon the recovery of activity of interactive enzyme systems comprising enzymes, coenzymes, catalysts, cofactors, substrates or any other necessary reagents. The invention provides a vital process for expediting sterility verification before utilization of the articles thought to be sterilized. The invention involves the rapid detection of any surviving interactive enzymatic activity which directly relates to the probability of any biological spores surviving in a test sample. An absence of a change indicates that the sterilization process had inactivated the enzyme system thereby preventing the interactive reaction from taking place which is a rapid equivalent to directly detecting the survivability of bacterial spores in a similar test.Type: GrantFiled: January 30, 1995Date of Patent: January 23, 1996Assignee: Medical College of OhioInventors: Jeffrey C. Burnham, George J. Hageage, Douglas Jambard-Sweet, Judy Hendricks
-
Patent number: 5438051Abstract: A family of benzochlorins, a family of verdins, a family of porphyrin derivatives and metal complexes thereof are disclosed. The benzochlorins have the formula of FIG. 3 of the attached drawings; their metal complexes have the formula of FIG. 1 . The verdins have the formula of FIG. 4 of the attached drawings; their metal complexes have the formula of FIG. 2. The porphyrin derivatives have the formula of FIG. 7 of the attached drawings; their metal complexes have the formula of FIG. 8. Solutions of the benzochlorins, verdins, porphyrin derivatives and metal complexes which are physiologically acceptable for intravenous administration are also disclosed, as are emulsions or suspensions of the solutions, and compositions which additionally include cyclodextrin, and wherein the molecules of the benzochlorin, verdin, porphyrin derivative or metal complex are encapsulated within the molecules of the cyclodextrin. The solvent for the solutions can be a product of the reaction of ethylene oxide with castor oil.Type: GrantFiled: October 4, 1993Date of Patent: August 1, 1995Assignees: University of Toledo, Medical College of OhioInventors: Alan R. Morgan, Steven H. Selman
-
Patent number: 5424305Abstract: Purified imines of porphyrins, chlorins, bateriochlorins, chlorophylls, bacteriochlorophylls, purpurins, reduced purpurins, verdins, Diels Alder adducts, benzochlorins and metal complexes of the foregoing imines are disclosed for retarding growth of cancer tumors such as bladder tumors. The formulas of the benzochlorinimines and of the benzochlorinimine metal complexes are set forth below: ##STR1## In specific examples, M in the metal complexes is a copper cation that is complexed with two of the nitrogens of the benzochlorinimine R' and R"" are methyl, and R1 through R8 are ethyl.Type: GrantFiled: November 24, 1993Date of Patent: June 13, 1995Assignees: The University of Toledo, Medical College of OhioInventors: Dimitris Skalkos, Steven H. Selman, James A. Hampton
-
Patent number: 5413918Abstract: The subject invention concerns novel polynucleotide sequences which code for polypeptides which bind IgA. A further aspect of the invention are hybrid proteins (and genes encoding these hybrid proteins) which comprise binding domains for both IgA and IgG.Type: GrantFiled: August 18, 1993Date of Patent: May 9, 1995Assignee: Medical College of OhioInventor: Ervin Faulmann